SCHEMBL2519281

SCHEMBL2519281

OC[C@H]1CCCN1CCCOc1n[nH]c2ccnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 19/20 0.66
EGFR P00533 17/20 0.66
KCNH2 Q12809 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1406604 0.92 ERBB2 (0.76) ERBB2EGFRKCNH2
SCHEMBL1406580 0.88 ERBB2 (0.76) ERBB2EGFRKCNH2
SCHEMBL1406740 0.88 ERBB2 (0.76) ERBB2EGFRKCNH2
SCHEMBL2515689 0.88 ERBB2 (0.55) ERBB2EGFRKCNH2
SCHEMBL2543368 0.85 ERBB2 (0.56) ERBB2EGFRKCNH2
SCHEMBL2523722 0.83 ERBB2 (0.79) ERBB2EGFR
SCHEMBL2519205 0.83 ERBB2 (0.83) ERBB2EGFRKCNH2
SCHEMBL2514377 0.83 ERBB2 (0.67) ERBB2EGFR
SCHEMBL2518693 0.83 ERBB2 (0.67) ERBB2EGFR
SCHEMBL2538841 0.81 ERBB2 (0.67) ERBB2EGFRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838712-B8 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2011-10-12 EP claimed
EP-1838712-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2007-10-03 EP claimed
WO-2006064196-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2006-06-22 WO claimed